← 產業報告目錄

Pharmaceutical-Grade Sodium Chloride Market by Grade (API-NaCl, HD-NaCl), Application (Injectables /Intravenous Solutions, Dialysis, Oral Rehydration Salts, Hemofiltration Solutions, Mechanical Cleansing Solutions), and Region - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Chemicals & Materials出版日期 2025-12-02頁數 253報告編號 CH3339

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The pharmaceutical-grade sodium chloride market size is estimated to be USD 0.59 billion in 2025 and is projected to reach USD 0.77 billion by 2030, at a CAGR of 5.6% from 2025 to 2030. The pharmaceutical-grade sodium chloride market will expand owing to the rise in the demand for intravenous fluids, the injectable formulations, and dialysis solutions as the prevalence of chronic diseases like chronic kidney disease (CKD), diabetes, and dehydration disorders continues to rise. The increased production of pharmaceuticals and biologics, including in the emerging economies, is also contributing to the demand for high-purity sodium chloride that is pharmacopeially acceptable. Investment in infrastructure facilities, government expenditure on critical care, and enhancements to supply chain facilities are also driving the market's growth. “HD-NaCl segment is projected to exhibit the highest CAGR from 2025 to 2030” The HD-NaCl is expected to record the highest CAGR in the pharmaceutical-grade sodium chloride market during the forecast period, owing to the rising demand for critical care therapies and hydration therapies provided in hospitals. Consumption of HD sodium chloride is on the rise. It is cheaper and can be produced in large quantities, making it the preferred choice over API sodium chloride for large-scale pharmaceutical and clinical usage. “Dialysis segment is projected to capture the largest market share in 2030” The largest application in the pharmaceutical-grade sodium chloride market is dialysis due to the rapidly rising incidences of CKD associated with older people, diabetes, and hypertension. The growth of dialysis facilities and the introduction of home dialysis units worldwide only escalates the market demand. The dialytic modalities of hemodialysis and peritoneal dialysis necessitate constant and high-volume utilization of pharmaceutical-grade sodium chloride to formulate the dialysates. “Asia Pacific pharmaceutical-grade sodium chloride market is projected to grow at the highest CAGR during the forecast period” The Asia Pacific is experiencing high growth in the pharmaceutical-grade sodium chloride market due to the rapid development of the pharmaceutical and biologics production industry, as well as increased investment in hospital and dialysis infrastructure. Favorable government policies and low cost of production deter competitive imported pharmaceutical-grade sodium chloride production. The increased use of modern healthcare in India, China, and Southeast Asia is reinforcing market acceleration. By Company Type: Tier 1 - 25%, Tier 2 - 42%, and Tier 3 - 33% By Designation: C-level Executives - 20%, Directors - 30%, and Others - 50% By Region: North America - 20%, Europe - 10%, Asia Pacific - 40%, South America - 10%, and Middle East & Africa - 20% Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: <USD 500 million Companies Covered: K+S Aktiengesellschaft (Germany), Südwestdeutsche Salzwerke AG (Germany), Dominion Salt (New Zealand), Morton Salt, Inc. (US), and Salinen Austria AG (Austria), among other companies, are covered in the report. The study includes an in-depth competitive analysis of these key players in the pharmaceutical-grade sodium chloride market, with their company profiles, recent developments, and key market strategies. Research Coverage This research report categorizes the pharmaceutical-grade sodium chloride market based on grade (API-NaCl and HD-NaCl), application (injectables/intravenous solutions, dialysis, oral rehydration salts, hemofiltration solutions, mechanical cleansing solutions, and other applications), and region (Asia Pacific, North America, Europe, South America, and the Middle East & Africa). The report’s scope covers detailed information regarding the drivers, restraints, challenges, and opportunities influencing the growth of the market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products offered, and key strategies, such as partnerships, expansions, and acquisitions, associated with the market. This report also covers a competitive analysis of upcoming startups in the pharmaceutical-grade sodium chloride market ecosystem. Reasons to Buy the Report The report will provide market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall pharmaceutical-grade sodium chloride market and its subsegments. This report will help stakeholders understand the competitive landscape, gain deeper insights into positioning their businesses more effectively, and develop suitable go-to-market strategies. The report will help stakeholders understand the market and provide them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following points: Analysis of key drivers (Rising dialysis treatments), restraints (Complex regulatory approvals), opportunities (Rising healthcare investment in developing regions), and challenges (Audits and documentation burdens) • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the pharmaceutical-grade sodium chloride market • Market Development: Comprehensive information about profitable markets–the report analyzes the pharmaceutical-grade sodium chloride market across varied regions • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the pharmaceutical-grade sodium chloride market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as K+S Aktiengesellschaft (Germany), Südwestdeutsche Salzwerke AG (Germany), Dominion Salt (New Zealand), Morton Salt, Inc. (US), Salinen Austria AG (Austria)
目錄 Table of Contents
1 INTRODUCTION 25 1.1 STUDY OBJECTIVES 25 1.2 MARKET DEFINITION 25 1.3 STUDY SCOPE 26 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 26 1.3.2 INCLUSIONS AND EXCLUSIONS 26 1.3.3 YEARS CONSIDERED 27 1.3.4 CURRENCY CONSIDERED 27 1.3.5 UNIT CONSIDERED 27 1.4 STAKEHOLDERS 28 1.5 SUMMARY OF STRATEGIC CHANGES 28 2 EXECUTIVE SUMMARY 29 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 29 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 30 2.3 DISRUPTIVE TRENDS SHAPING PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 31 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 32 2.5 SNAPSHOT: ASIA PACIFIC MARKET SIZE AND FORECAST 33 3 PREMIUM INSIGHTS 34 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 34 3.2 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE AND REGION 35 3.3 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM 35 3.4 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION 36 3.5 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY 36 4 MARKET OVERVIEW 37 4.1 INTRODUCTION 37 4.2 MARKET DYNAMICS 38 4.2.1 DRIVERS 38 4.2.1.1 Rising dialysis treatments 38 4.2.1.2 Strong demand for pharmaceutical-grade sodium chloride in North America and Europe 40 4.2.1.3 Emerging markets driving healthcare expansion and increasing demand 41 4.2.2 RESTRAINTS 41 4.2.2.1 Complex regulatory approvals 41 4.2.2.2 Dependence on stable supply of raw salt 42   4.2.3 OPPORTUNITIES 42 4.2.3.1 Rising healthcare investment in developing regions 42 4.2.3.2 Partnerships with hospitals and pharmaceutical companies 43 4.2.4 CHALLENGES 43 4.2.4.1 Strict audits and documentation burdens 43 4.2.4.2 Competition from local low-cost producers 44 4.3 UNMET NEEDS AND WHITE SPACES 44 4.3.1 UNMET NEEDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 44 4.3.1.1 Need for higher purity and specialized grades 44 4.3.1.2 Digitalization and supply chain transparency 45 4.3.1.3 Enhanced technical support and quality services 45 4.3.1.4 Flexible and long-term supply models 45 4.3.1.5 Skilled quality teams and regulatory assurance 45 4.3.2 WHITE SPACE OPPORTUNITIES 45 4.3.2.1 Expansion into emerging and underserved markets 45 4.3.2.2 Development of specialty and high-performance grades 46 4.3.2.3 Digital quality systems and traceability platforms 46 4.3.2.4 Enhanced technical services and regulatory support 46 4.3.2.5 Integrated supply and capacity-reliability solutions 46 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 47 4.4.1 INTERCONNECTED MARKETS 47 4.4.2 CROSS-SECTOR OPPORTUNITIES 47 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 48 4.5.1 KEY MOVES AND STRATEGIC FOCUS 48 5 INDUSTRY TRENDS 49 5.1 PORTER’S FIVE FORCES’ ANALYSIS 49 5.1.1 THREAT OF NEW ENTRANTS 50 5.1.2 THREAT OF SUBSTITUTES 50 5.1.3 BARGAINING POWER OF SUPPLIERS 50 5.1.4 BARGAINING POWER OF BUYERS 51 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 51 5.2 MACROECONOMIC ANALYSIS 52 5.2.1 INTRODUCTION 52 5.2.2 GDP TRENDS AND FORECASTS 52 5.2.3 URBANIZATION AND DEMOGRAPHIC SHIFTS 53 5.2.4 TRADE AND GLOBAL SUPPLY CHAIN DYNAMICS 54 5.3 VALUE CHAIN ANALYSIS 55 5.3.1 RAW MATERIAL PROCUREMENT AND ACQUISITION 56 5.3.2 PROCESSING, REFINING, AND QUALITY ASSURANCE 56 5.3.3 DISTRIBUTION, LOGISTICS, AND SUPPLY CHAIN MANAGEMENT 57 5.3.4 CONVERSION TO END-USE PHARMACEUTICAL PRODUCTS 57 5.4 ECOSYSTEM ANALYSIS 57 5.5 PRICING ANALYSIS 58 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY GRADE 59 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 59 5.6 TRADE ANALYSIS 60 5.6.1 IMPORT SCENARIO 61 5.6.2 EXPORT SCENARIO 62 5.7 KEY CONFERENCES AND EVENTS, 2025–2026 64 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 64 5.9 CASE STUDY ANALYSIS 65 5.9.1 EFFICIENT PRODUCTION OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE FROM ROCK SALT AT ENASEL, ALGERIA 65 5.9.2 TRANSFORMING LOW-QUALITY SOLAR SALT INTO PHARMACEUTICAL-GRADE SODIUM CHLORIDE IN BANGLADESH 66 5.10 IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 66 5.10.1 INTRODUCTION 66 5.10.2 KEY TARIFF RATES 67 5.10.3 PRICE IMPACT ANALYSIS 67 5.10.4 KEY IMPACT ON VARIOUS REGIONS 68 5.10.5 IMPACT ON APPLICATIONS 68 6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS 69 6.1 KEY TECHNOLOGIES 69 6.1.1 VACUUM SALT PRODUCTION 69 6.1.2 MECHANICAL VAPOR RECOMPRESSION (MVR) & MULTIPLE-EFFECT EVAPORATION (MEE) 69 6.1.3 RECRYSTALLIZATION 69 6.1.4 COLD BRINE LEACHING & CHEMICAL PRECIPITATION 69 6.2 COMPLEMENTARY TECHNOLOGIES 69 6.2.1 PARTICLE SIZE CONTROL, SIEVING, AND GRANULATION 70 6.2.2 DRYING TECHNOLOGY (HOT AIR & FLUID BED DRYING) 70 6.2.3 PAT & PROCESS AUTOMATION (SCADA, DCS, INLINE QUALITY MONITORING) 70 6.3 ADJACENT TECHNOLOGIES 70 6.3.1 STERILE INTRAVENOUS FLUID, DIALYSIS, AND ORS PRODUCTION SYSTEMS 70 6.3.2 CLEANROOM, HVAC, AND GMP PACKAGING TECHNOLOGIES 70 6.4 TECHNOLOGY/PRODUCT ROADMAP 70 6.4.1 SHORT-TERM (2025–2027) | DIGITAL TRANSITION AND PRODUCTION OPTIMIZATION PHASE 70 6.4.2 MID-TERM (2027–2030): SUSTAINABLE PRODUCTION & SUPPLY CHAIN INTEGRATION 71 6.4.3 LONG-TERM (2030–2035+): BIOPROCESS INTEGRATION & ON-SITE PHARMACEUTICAL BRINE SYSTEMS 72 6.5 PATENT ANALYSIS 72 6.5.1 INTRODUCTION 72 6.5.2 APPROACH 73 6.5.3 TOP APPLICANTS 73 6.6 FUTURE APPLICATIONS 75 6.6.1 ADVANCED APPLICATIONS IN INJECTABLES, DIALYSIS, AND BIOPROCESSING SYSTEMS 75 6.7 IMPACT OF AI/GEN AI ON PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 76 6.7.1 TOP USE CASES AND MARKET POTENTIAL 76 6.7.2 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 77 6.7.3 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 77 6.8 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 78 6.8.1 K+S AKTIENGESELLSCHAFT ENABLES CRITICAL PHARMACEUTICAL SUPPLY SUPPORT DURING GLOBAL COVID-19 VACCINATION ROLLOUT 78 7 SUSTAINABILITY AND REGULATORY LANDSCAPE 79 7.1 REGIONAL REGULATIONS AND COMPLIANCE 79 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 7.1.2 INDUSTRY STANDARDS 82 7.2 SUSTAINABILITY INITIATIVES 83 7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE 83 7.2.1.1 Carbon Impact Reduction 84 7.2.1.2 Eco-Applications 84 7.3 CERTIFICATIONS, LABELING, ECO-STANDARDS 85 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 87 8.1 DECISION-MAKING PROCESS 87 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 89 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 89 8.2.2 BUYING CRITERIA 90 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 91 8.4 UNMET NEEDS FROM VARIOUS APPLICATIONS 93 8.5 MARKET PROFITABILITY 93 8.5.1 REVENUE POTENTIAL 93 8.5.2 COST DYNAMICS 94 8.5.3 MARGIN OPPORTUNITIES, BY APPLICATION 94   9 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE 95 9.1 INTRODUCTION 96 9.2 HD-NACL 97 9.2.1 UNMATCHED STABILITY, HEIGHT, AND LIFTING POWER TO DRIVE DEMAND 97 9.3 API-NACL 97 9.3.1 HIGH REGULATORY COMPLIANCE, PURITY ASSURANCE, AND FUNCTIONAL PERFORMANCE TO AUGMENT DEMAND 97 10 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM 99 10.1 INTRODUCTION 100 10.2 LIQUID 101 10.2.1 GROWING DEMAND FOR ORAL ELECTROLYTE THERAPIES TO DRIVE DEMAND 101 10.3 SOLID 101 10.3.1 RISING GLOBAL HOSPITALIZATION RATES TO AUGMENT DEMAND 101 11 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION 102 11.1 INTRODUCTION 103 11.2 DIALYSIS 104 11.2.1 GROWING DIALYSIS PATIENT POPULATION TO FUEL MARKET GROWTH 104 11.3 INJECTABLES 105 11.3.1 GROWING USE OF IV THERAPIES AND SURGICAL PROCEDURES TO DRIVE DEMAND 105 11.4 ORAL REHYDRATION SALTS 105 11.4.1 GROWING GLOBAL NEED FOR EFFECTIVE DEHYDRATION MANAGEMENT TO DRIVE DEMAND 105 11.5 HEMOFILTRATION SOLUTIONS 106 11.5.1 ADVANCED RENAL REPLACEMENT REQUIREMENTS TO ACCELERATE DEMAND 106 11.6 MECHANICAL CLEANING SOLUTIONS 107 11.6.1 INCREASING SURGICAL ACTIVITIES AND HOSPITAL HYGIENE STANDARDS TO DRIVE DEMAND 107 11.7 OTHER APPLICATIONS 107 12 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION 109 12.1 INTRODUCTION 110 12.2 ASIA PACIFIC 111 12.2.1 CHINA 115 12.2.1.1 Pharmaceutical industry and shift toward advanced drug development to drive market 115 12.2.2 JAPAN 116 12.2.2.1 Accelerating aging population and rising healthcare demand to drive market 116 12.2.3 INDIA 118 12.2.3.1 Growing generic injectable drug industry to drive market 118   12.2.4 SOUTH KOREA 120 12.2.4.1 Rapidly aging population and rising healthcare demand to propel market 120 12.2.5 REST OF ASIA PACIFIC 122 12.3 EUROPE 124 12.3.1 GERMANY 128 12.3.1.1 Rising renal replacement therapy demand to boost consumption 128 12.3.2 FRANCE 130 12.3.2.1 Growing adoption of home hemodialysis 130 12.3.3 UK 132 12.3.3.1 CKD prevalence and aging population to accelerate market 132 12.3.4 ITALY 134 12.3.4.1 Expanding healthcare infrastructure to drive demand 134 12.3.5 SPAIN 136 12.3.5.1 Strong organ donation infrastructure and rising dialysis volume to accelerate market growth 136 12.3.6 NETHERLANDS 138 12.3.6.1 Increasing CKD incidence and elderly population expansion to support market growth 138 12.3.7 IRELAND 140 12.3.7.1 Increasing incidence of kidney failure and expanding renal care needs to boost market 140 12.3.8 TURKEY 142 12.3.8.1 High incidence of end-stage kidney disease to boost market 142 12.3.9 RUSSIA 143 12.3.9.1 Expanding dialysis centers and rising CKD burden to propel market 143 12.3.10 REST OF EUROPE 145 12.4 NORTH AMERICA 147 12.4.1 US 150 12.4.1.1 Aging population increasing hospital and infusion needs to boost market 150 12.4.2 CANADA 152 12.4.2.1 Rising CKD and expanding dialysis needs to boost market 152 12.4.3 MEXICO 154 12.4.3.1 Rapidly aging population to propel the market 154 12.5 SOUTH AMERICA 155 12.5.1 BRAZIL 158 12.5.1.1 Rising CKD burden and rapid population aging fueling the demand 158 12.5.2 ARGENTINA 160 12.5.2.1 Healthcare modernization and rising chronic disease burden to augment market 160 12.5.3 REST OF SOUTH AMERICA 161   12.6 MIDDLE EAST & AFRICA 163 12.6.1 GCC COUNTRIES 165 12.6.1.1 Saudi Arabia 167 12.6.1.1.1 High CKD and diabetes burden paired with Vision 2030 healthcare expansion to drive market 167 12.6.1.2 UAE 169 12.6.1.2.1 High diabetes and CKD burden to boost market 169 12.6.1.3 Rest of GCC countries 170 12.6.2 SOUTH AFRICA 172 12.6.2.1 Expanding healthcare & dialysis infrastructure to drive market 172 12.6.3 REST OF MIDDLE EAST & AFRICA 174 13 COMPETITIVE LANDSCAPE 176 13.1 OVERVIEW 176 13.2 KEY PLAYER STRATEGIES 176 13.3 REVENUE ANALYSIS 177 13.4 MARKET SHARE ANALYSIS 177 13.5 COMPANY VALUATION AND FINANCIAL METRICS 180 13.5.1 COMPANY VALUATION 180 13.5.2 FINANCIAL METRICS 181 13.6 BRAND/PRODUCT COMPARISON 183 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 184 13.7.1 STARS 184 13.7.2 EMERGING LEADERS 184 13.7.3 PERVASIVE PLAYERS 184 13.7.4 PARTICIPANTS 184 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 186 13.7.5.1 Company footprint 186 13.7.5.2 Region footprint 187 13.7.5.3 Grade footprint 187 13.7.5.4 Product form footprint 188 13.7.5.5 Application footprint 188 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 189 13.8.1 PROGRESSIVE COMPANIES 189 13.8.2 RESPONSIVE COMPANIES 189 13.8.3 DYNAMIC COMPANIES 189 13.8.4 STARTING BLOCKS 189 13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 191 13.8.6 DETAILED LIST OF KEY STARTUPS/SMES 191 13.8.7 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 192   13.9 COMPETITIVE SCENARIO 193 13.9.1 DEALS 193 13.9.2 EXPANSIONS 194 13.9.3 OTHER DEVELOPMENTS 194 14 COMPANY PROFILES 195 14.1 KEY PLAYERS 195 14.1.1 K+S AKTIENGESELLSCHAFT 195 14.1.1.1 Business overview 195 14.1.1.2 Products/Solutions/Services offered 196 14.1.1.3 Recent developments 197 14.1.1.3.1 Others 197 14.1.1.4 MnM view 197 14.1.1.4.1 Key strengths 197 14.1.1.4.2 Strategic choices 198 14.1.1.4.3 Weaknesses and competitive threats 198 14.1.2 SÜDWESTDEUTSCHE SALZWERKE AG 199 14.1.2.1 Business overview 199 14.1.2.2 Products/Solutions/Services offered 200 14.1.2.3 MnM view 201 14.1.2.3.1 Key strengths 201 14.1.2.3.2 Strategic choices 201 14.1.2.3.3 Weaknesses and competitive threats 202 14.1.3 DOMINION SALT 203 14.1.3.1 Business overview 203 14.1.3.2 Products/Solutions/Services offered 203 14.1.3.3 MnM view 204 14.1.3.3.1 Key strengths 204 14.1.3.3.2 Strategic choices 204 14.1.3.3.3 Weaknesses and competitive threats 204 14.1.4 MORTON SALT, INC. 205 14.1.4.1 Business overview 205 14.1.4.2 Products/Solutions/Services offered 205 14.1.4.3 MnM view 206 14.1.4.3.1 Key strengths 206 14.1.4.3.2 Strategic choices 206 14.1.4.3.3 Weaknesses and competitive threats 206 14.1.5 SALINEN AUSTRIA AG 207 14.1.5.1 Business overview 207 14.1.5.2 Products/Solutions/Services offered 207 14.1.5.3 MnM view 208 14.1.5.3.1 Key strengths 208 14.1.5.3.2 Strategic choices 208 14.1.5.3.3 Weaknesses and competitive threats 208 14.1.6 MERCK KGAA 209 14.1.6.1 Business overview 209 14.1.6.2 Products/Solutions/Services offered 211 14.1.6.3 Recent developments 211 14.1.6.3.1 Expansions 211 14.1.6.4 MnM view 212 14.1.7 GROUPE SALINS 213 14.1.7.1 Business overview 213 14.1.7.2 Products/Solutions/Services offered 214 14.1.7.3 Recent developments 214 14.1.7.3.1 Deals 214 14.1.7.4 MnM view 215 14.1.8 HUB SALT 216 14.1.8.1 Business overview 216 14.1.8.2 Products/Solutions/Services offered 216 14.1.8.3 MnM view 217 14.1.9 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD. 218 14.1.9.1 Business overview 218 14.1.9.2 Products/Solutions/Services offered 218 14.1.9.3 MnM view 219 14.1.10 US SALT 220 14.1.10.1 Business overview 220 14.1.10.2 Products/Solutions/Services offered 220 14.1.10.3 MnM view 220 14.2 OTHER PLAYERS 221 14.2.1 NANDU CHEMICALS 221 14.2.2 MACCO ORGANIQUES, S.R.O. 222 14.2.3 J J CHEMICALS 223 14.2.4 SALT MINERALS GMBH 224 14.2.5 HITECH MINERALS AND CHEMICALS GROUP 225 14.2.6 TIANJIN HENGHAIXIN INTERNATIONAL TRADING CO., LTD. 226 14.2.7 MARKHOR SALT CO. 227 14.2.8 ABHAY AQUA CHEM 228 14.2.9 HAWKINS 229 14.2.10 RCI LABSCAN LIMITED 230 14.2.11 GLENTHAM LIFE SCIENCES LIMITED 231 14.2.12 FENGCHEN GROUP CO., LTD 232 14.2.13 DHANRAJ SUGAR PVT. LTD. 233 14.2.14 SD FINE-CHEM LTD 234 14.2.15 VM CHEMICALS 235 15 RESEARCH METHODOLOGY 236 15.1 RESEARCH DATA 236 15.1.1 SECONDARY DATA 236 15.1.1.1 Key data from secondary sources 237 15.1.2 PRIMARY DATA 237 15.1.2.1 Key data from primary sources 238 15.1.2.2 Key industry insights 238 15.2 MARKET SIZE ESTIMATION 239 15.3 BASE NUMBER CALCULATION 240 15.3.1 DEMAND-SIDE APPROACH 240 15.3.2 SUPPLY-SIDE APPROACH 241 15.4 MARKET FORECAST APPROACH 241 15.4.1 SUPPLY SIDE 241 15.4.2 DEMAND SIDE 241 15.5 DATA TRIANGULATION 241 15.6 FACTOR ANALYSIS 242 15.7 RESEARCH ASSUMPTIONS 243 15.8 RESEARCH LIMITATIONS AND RISK ASSESSMENT 244 16 APPENDIX 245 16.1 DISCUSSION GUIDE 245 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 249 16.3 CUSTOMIZATION OPTIONS 251 16.4 RELATED REPORTS 251 16.5 AUTHOR DETAILS 252
圖表清單 List of Tables & Figures
TABLE 1 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: IMPACT OF PORTER’S FIVE FORCES ANALYSIS 50 TABLE 2 GLOBAL GDP GROWTH PROJECTION, 2021–2028 (USD TRILLION) 53 TABLE 3 ROLE OF COMPANIES IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE ECOSYSTEM 58 TABLE 4 AVERAGE SELLING PRICE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE OFFERED BY KEY PLAYERS, BY GRADE, 2024 (USD/KG) 59 TABLE 5 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY REGION, 2023–2025 (USD/KG) 60 TABLE 6 IMPORT DATA FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 62 TABLE 7 EXPORT DATA FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 63 TABLE 8 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 64 TABLE 9 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: LIST OF MAJOR PATENTS: 2024 74 TABLE 10 TOP USE CASES AND MARKET POTENTIAL 76 TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 14 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 15 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 16 GLOBAL INDUSTRY STANDARDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 82 TABLE 17 CERTIFICATIONS, LABELING, ECO-STANDARDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 85 TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%) 90 TABLE 19 KEY BUYING CRITERIA, BY APPLICATION 91 TABLE 20 UNMET NEEDS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET IN KEY APPLICATIONS 93 TABLE 21 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 96 TABLE 22 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTONS) 97 TABLE 23 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 100 TABLE 24 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTONS) 101 TABLE 25 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 104 TABLE 26 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTONS) 104 TABLE 27 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 28 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY REGION, 2023–2030 (KILOTON) 111 TABLE 29 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 30 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (KILOTON) 113 TABLE 31 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 113 TABLE 32 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 113 TABLE 33 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 113 TABLE 34 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTON) 114 TABLE 35 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 114 TABLE 36 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 114 TABLE 37 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 115 TABLE 38 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 115 TABLE 39 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 116 TABLE 40 CHINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 116 TABLE 41 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 117 TABLE 42 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 117 TABLE 43 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 117 TABLE 44 JAPAN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 118 TABLE 45 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 119 TABLE 46 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 119 TABLE 47 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 119 TABLE 48 INDIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 120 TABLE 49 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 121 TABLE 50 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 121 TABLE 51 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 121 TABLE 52 SOUTH KOREA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 122 TABLE 53 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 123 TABLE 54 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 123 TABLE 55 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 123 TABLE 56 REST OF ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 124 TABLE 57 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 58 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (KILOTON) 126 TABLE 59 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 126 TABLE 60 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 126 TABLE 61 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 127 TABLE 62 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTON) 127 TABLE 63 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127 TABLE 64 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 128 TABLE 65 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 129 TABLE 66 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 129 TABLE 67 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 129 TABLE 68 GERMANY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 130 TABLE 69 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 131 TABLE 70 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 131 TABLE 71 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131 TABLE 72 FRANCE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 132 TABLE 73 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 133 TABLE 74 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 133 TABLE 75 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 133 TABLE 76 UK: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 134 TABLE 77 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 134 TABLE 78 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 135 TABLE 79 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 135 TABLE 80 ITALY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 135 TABLE 81 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 136 TABLE 82 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 137 TABLE 83 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 137 TABLE 84 SPAIN: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 137 TABLE 85 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 138 TABLE 86 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 139 TABLE 87 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 139 TABLE 88 NETHERLANDS: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 139 TABLE 89 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 140 TABLE 90 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 141 TABLE 91 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 141 TABLE 92 IRELAND: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 141 TABLE 93 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 142 TABLE 94 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 142 TABLE 95 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 143 TABLE 96 TURKEY: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 143 TABLE 97 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 144 TABLE 98 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 144 TABLE 99 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 144 TABLE 100 RUSSIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 145 TABLE 101 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 146 TABLE 102 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 146 TABLE 103 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 104 REST OF EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 147 TABLE 105 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 106 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (KILOTON) 148 TABLE 107 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 148 TABLE 108 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 148 TABLE 109 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 149 TABLE 110 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTON) 149 TABLE 111 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 149 TABLE 112 NORTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 150 TABLE 113 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 151 TABLE 114 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 151 TABLE 115 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151 TABLE 116 US: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 152 TABLE 117 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 152 TABLE 118 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 153 TABLE 119 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 153 TABLE 120 CANADA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 153 TABLE 121 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 154 TABLE 122 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 154 TABLE 123 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 155 TABLE 124 MEXICO: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 155 TABLE 125 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 126 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (KILOTON) 156 TABLE 127 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 156 TABLE 128 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY GRADE, 2023–2030 (KILOTON) 156 TABLE 129 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 157 TABLE 130 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTON) 157 TABLE 131 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 132 SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 158 TABLE 133 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 158 TABLE 134 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 159 TABLE 135 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 159 TABLE 136 BRAZIL: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 159 TABLE 137 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 160 TABLE 138 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 160 TABLE 139 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 161 TABLE 140 ARGENTINA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 161 TABLE 141 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 162 TABLE 142 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 162 TABLE 143 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 162 TABLE 144 REST OF SOUTH AMERICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 163 TABLE 145 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 146 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY COUNTRY, 2023–2030 (KILOTON) 164 TABLE 147 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 164 TABLE 148 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 164 TABLE 149 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (USD MILLION) 164 TABLE 150 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY PRODUCT FORM, 2023–2030 (KILOTON) 165 TABLE 151 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 165 TABLE 152 MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 165 TABLE 153 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 166 TABLE 154 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 166 TABLE 155 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 166 TABLE 156 GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 167 TABLE 157 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 167 TABLE 158 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 168 TABLE 159 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 168 TABLE 160 SAUDI ARABIA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 168 TABLE 161 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 169 TABLE 162 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 169 TABLE 163 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 170 TABLE 164 UAE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 170 TABLE 165 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 171 TABLE 166 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 171 TABLE 167 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171 TABLE 168 REST OF GCC COUNTRIES: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 172 TABLE 169 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 172 TABLE 170 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 173 TABLE 171 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 173 TABLE 172 SOUTH AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 173 TABLE 173 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (USD MILLION) 174 TABLE 174 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY GRADE, 2023–2030 (KILOTON) 174 TABLE 175 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 174 TABLE 176 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, BY APPLICATION, 2023–2030 (KILOTON) 175 TABLE 177 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS BETWEEN JANUARY 2021 AND NOVEMBER 2025 176 TABLE 178 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DEGREE OF COMPETITION 178 TABLE 179 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: REGION FOOTPRINT 187 TABLE 180 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: GRADE FOOTPRINT 187 TABLE 181 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: PRODUCT FORM FOOTPRINT 188 TABLE 182 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: APPLICATION FOOTPRINT 188 TABLE 183 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 191 TABLE 184 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 192 TABLE 185 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DEALS, JANUARY 2021–NOVEMBER 2025 193 TABLE 186 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: EXPANSIONS, JANUARY 2021–NOVEMBER 2025 194 TABLE 187 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: OTHER DEVELOPMENTS, JANUARY 2021–NOVEMBER 2025 194 TABLE 188 K+S AKTIENGESELLSCHAFT: COMPANY OVERVIEW 195 TABLE 189 K+S AKTIENGESELLSCHAFT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 196 TABLE 190 K+S AKTIENGESELLSCHAFT: OTHERS 197 TABLE 191 SÜDWESTDEUTSCHE SALZWERKE AG: COMPANY OVERVIEW 199 TABLE 192 SÜDWESTDEUTSCHE SALZWERKE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 200 TABLE 193 DOMINION SALT: COMPANY OVERVIEW 203 TABLE 194 DOMINION SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 203 TABLE 195 MORTON SALT, INC.: COMPANY OVERVIEW 205 TABLE 196 MORTON SALT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 205 TABLE 197 SALINEN AUSTRIA AG: COMPANY OVERVIEW 207 TABLE 198 SALINEN AUSTRIA AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 207 TABLE 199 MERCK KGAA: COMPANY OVERVIEW 209 TABLE 200 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 211 TABLE 201 MERCK KGAA: EXPANSIONS 211 TABLE 202 GROUPE SALINS: COMPANY OVERVIEW 213 TABLE 203 GROUPE SALINS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214 TABLE 204 GROUPE SALINS: DEALS 214 TABLE 205 HUB SALT: COMPANY OVERVIEW 216 TABLE 206 HUB SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 216 TABLE 207 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 218 TABLE 208 JIANGSU PROVINCE QINFEN PHARMACEUTICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 218 TABLE 209 US SALT: COMPANY OVERVIEW 220 TABLE 210 US SALT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 220 TABLE 211 NANDU CHEMICALS: COMPANY OVERVIEW 221 TABLE 212 MACCO ORGANIQUES, S.R.O.: COMPANY OVERVIEW 222 TABLE 213 J J CHEMICALS: COMPANY OVERVIEW 223 TABLE 214 SALT MINERALS GMBH: COMPANY OVERVIEW 224 TABLE 215 HITECH MINERALS AND CHEMICALS GROUP: COMPANY OVERVIEW 225 TABLE 216 TIANJIN HENGHAIXIN INTERNATIONAL TRADING CO., LTD.: COMPANY OVERVIEW 226 TABLE 217 MARKHOR SALT CO.: COMPANY OVERVIEW 227 TABLE 218 ABHAY AQUA CHEM: COMPANY OVERVIEW 228 TABLE 219 HAWKINS: COMPANY OVERVIEW 229 TABLE 220 RCI LABSCAN LIMITED: COMPANY OVERVIEW 230 TABLE 221 GLENTHAM LIFE SCIENCES LIMITED: COMPANY OVERVIEW 231 TABLE 222 FENGCHEN GROUP CO., LTD: COMPANY OVERVIEW 232 TABLE 223 DHANRAJ SUGAR PVT. LTD.: COMPANY OVERVIEW 233 TABLE 224 SD FINE-CHEM LTD: COMPANY OVERVIEW 234 TABLE 225 VM CHEMICALS: COMPANY OVERVIEW 235 FIGURE 1 PHARMACEUTICAL-GRADE MARKET SEGMENTATION AND REGIONAL SCOPE 26 FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 29 FIGURE 3 GLOBAL PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, 2025–2030 30 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET (2021–2025) 30 FIGURE 5 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DURING FORECAST PERIOD 31 FIGURE 6 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET, 2024 32 FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 33 FIGURE 8 HIGH DEMAND FOR DIALYSIS TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 34 FIGURE 9 ASIA PACIFIC ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 35 FIGURE 10 LIQUID SEGMENT DOMINATED PHARMACEUTICAL-GRADE MARKET IN 2024 35 FIGURE 11 DIALYSIS SEGMENT ACCOUNTED FOR LARGEST SHARE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET IN 2024 36 FIGURE 12 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 36 FIGURE 13 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38 FIGURE 14 CHRONIC KIDNEY DISEASE RISING AS LEADING CAUSE OF DEATH WORLDWIDE 39 FIGURE 15 CHRONIC KIDNEY DISEASE PREVALENCE: EUROPE COMPARED TO GLOBAL LEVELS 40 FIGURE 16 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION (2022 VS. 2050) 40 FIGURE 17 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: PORTER’S FIVE FORCES ANALYSIS 49 FIGURE 18 NUMBER OF PEOPLE LIVING IN URBAN AND RURAL AREAS, WORLD (2010–2024) 54 FIGURE 19 GLOBAL TRADE IN MERCHANDISE, 2014–2024 54 FIGURE 20 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: VALUE CHAIN ANALYSIS 56 FIGURE 21 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: ECOSYSTEM ANALYSIS 58 FIGURE 22 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE OFFERED BY KEY PLAYERS, BY GRADE, 2024 (USD/KG) 59 FIGURE 23 AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE, BY REGION, 2023–2025 (USD/KG) 60 FIGURE 24 IMPORT SCENARIO FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 61 FIGURE 25 EXPORT SCENARIO FOR HS CODE 250100-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 63 FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65 FIGURE 27 LIST OF MAJOR PATENTS RELATED TO PHARMACEUTICAL-GRADE SODIUM CHLORIDE, 2015–2024 73 FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED FOR PHARMACEUTICAL-GRADE SODIUM CHLORIDE, 2015–2024 74 FIGURE 29 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DECISION-MAKING FACTORS 89 FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION 89 FIGURE 31 KEY BUYING CRITERIA, BY APPLICATION 90 FIGURE 32 ADOPTION BARRIERS & INTERNAL CHALLENGES 92 FIGURE 33 HD-NACL SEGMENT TO DOMINATE MARKET IN 2025 96 FIGURE 34 LIQUID SEGMENT TO DOMINATE MARKET IN 2025 100 FIGURE 35 DIALYSIS SEGMENT TO DOMINATE MARKET IN 2025 103 FIGURE 36 ASIA PACIFIC TO ACCOUNT FOR LARGEST SHARE OF PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET DURING FORECAST PERIOD 110 FIGURE 37 ASIA PACIFIC: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SNAPSHOT 112 FIGURE 38 EUROPE: PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SNAPSHOT 125 FIGURE 39 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 (USD BILLION) 177 FIGURE 40 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET SHARE ANALYSIS, 2024 178 FIGURE 41 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY VALUATION 181 FIGURE 42 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: FINANCIAL MATRIX (EV/EBITDA RATIO) 181 FIGURE 43 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: YEAR-TO-DATE PRICE AND FIVE-YEAR STOCK BETA 182 FIGURE 44 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: BRAND/PRODUCT COMPARISON 183 FIGURE 45 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 185 FIGURE 46 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY FOOTPRINT 186 FIGURE 47 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 190 FIGURE 48 K+S AKTIENGESELLSCHAFT: COMPANY SNAPSHOT 196 FIGURE 49 SÜDWESTDEUTSCHE SALZWERKE AG: COMPANY SNAPSHOT 200 FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT 210 FIGURE 51 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: RESEARCH DESIGN 236 FIGURE 52 BREAKDOWN OF INTERVIEWS WITH EXPERTS 239 FIGURE 53 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 239 FIGURE 54 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 240 FIGURE 55 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: APPROACH 1 240 FIGURE 56 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET 241 FIGURE 57 PHARMACEUTICAL-GRADE SODIUM CHLORIDE MARKET: DATA TRIANGULATION 242

同分類最新報告（化學與材料）

查看化學與材料全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們